Correlation of IDH1/2 mutation with clinicopathologic factors and prognosis in anaplastic gliomas: a report of 203 patients from China.
作者： Chuan-Bao Zhang , Zhao-Shi Bao , Hong-Jun Wang , Wei Yan , Yan-Wei Liu
DOI: 10.1007/S00432-013-1519-9
关键词:
摘要: Purpose Isocitrate dehydrogenase (IDH) gene mutation is one of the most exciting new advances in these years. It has been reported that IDH frequently altered grade II and III gliomas. We aimed to identify frequency genes Chinese anaplastic glioma patients, association with other clinical molecular pathological features prognostic value it.
springer.com
sci-hub.se 参考文章(30)
Bao-shi Chen, Shou-wei Li, Xiao-guang Qiu, Huan Ren, Tao Jiang, Yun Cui, Wei Zhang, Antiangiogenic therapy with bevacizumab in recurrent malignant gliomas: analysis of the response and core pathway aberrations Chinese Medical Journal. ,vol. 122, pp. 1250- 1254 ,(2009)
JAE KYUNG MYUNG, HWA JIN CHO, CHUL-KEE PARK, SEUNG-KI KIM, JI HOON PHI, SUNG-HYE PARK, IDH1 mutation of gliomas with long-term survival analysis. Oncology Reports. ,vol. 28, pp. 1639- 1644 ,(2012) , 10.3892/OR.2012.1994
Pei Yang, Yongzhi Wang, Xiaoxia Peng, Gan You, Wei Zhang, Wei Yan, Zhaoshi Bao, Yinyan Wang, Xiaoguang Qiu, Tao Jiang, Management and survival rates in patients with glioma in China (2004–2010): a retrospective study from a single-institution Journal of Neuro-oncology. ,vol. 113, pp. 259- 266 ,(2013) , 10.1007/S11060-013-1103-9
Yongzhi Wang, Tao Jiang, Understanding high grade glioma: Molecular mechanism, therapy and comprehensive management Cancer Letters. ,vol. 331, pp. 139- 146 ,(2013) , 10.1016/J.CANLET.2012.12.024
Brian V. Geisbrecht, Stephen J. Gould, The HumanPICDGene Encodes a Cytoplasmic and Peroxisomal NADP+-dependent Isocitrate Dehydrogenase Journal of Biological Chemistry. ,vol. 274, pp. 30527- 30533 ,(1999) , 10.1074/JBC.274.43.30527
Wei Yan, Wei Zhang, Gan You, Zhaoshi Bao, Yongzhi Wang, Yanwei Liu, Chunsheng Kang, Yongping You, Lei Wang, Tao Jiang, None, Correlation of IDH1 Mutation with Clinicopathologic Factors and Prognosis in Primary Glioblastoma: A Report of 118 Patients from China PLoS ONE. ,vol. 7, pp. e30339- ,(2012) , 10.1371/JOURNAL.PONE.0030339
Akitake Mukasa, Shunsaku Takayanagi, Kuniaki Saito, Junji Shibahara, Yusuke Tabei, Kazuhide Furuya, Takafumi Ide, Yoshitaka Narita, Ryo Nishikawa, Keisuke Ueki, Nobuhito Saito, Significance of IDH mutations varies with tumor histology, grade, and genetics in Japanese glioma patients Cancer Science. ,vol. 103, pp. 587- 592 ,(2012) , 10.1111/J.1349-7006.2011.02175.X
D. W. Parsons, S. Jones, X. Zhang, J. C.-H. Lin, R. J. Leary, P. Angenendt, P. Mankoo, H. Carter, I-M. Siu, G. L. Gallia, A. Olivi, R. McLendon, B. A. Rasheed, S. Keir, T. Nikolskaya, Y. Nikolsky, D. A. Busam, H. Tekleab, L. A. Diaz, J. Hartigan, D. R. Smith, R. L. Strausberg, S. K. N. Marie, S. M. O. Shinjo, H. Yan, G. J. Riggins, D. D. Bigner, R. Karchin, N. Papadopoulos, G. Parmigiani, B. Vogelstein, V. E. Velculescu, K. W. Kinzler, An Integrated Genomic Analysis of Human Glioblastoma Multiforme Science. ,vol. 321, pp. 1807- 1812 ,(2008) , 10.1126/SCIENCE.1164382
Ichiyo Shibahara, Yukihiko Sonoda, Masayuki Kanamori, Ryuta Saito, Yoji Yamashita, Toshihiro Kumabe, Mika Watanabe, Hiroyoshi Suzuki, Shunsuke Kato, Chikashi Ishioka, Teiji Tominaga, IDH1/2 gene status defines the prognosis and molecular profiles in patients with grade III gliomas International Journal of Clinical Oncology. ,vol. 17, pp. 551- 561 ,(2012) , 10.1007/S10147-011-0323-2
J. S. Frenel, C. Leux, D. Loussouarn, A.-G. Le Loupp, F. Leclair, M. Aumont, A. Mervoyer, S. Martin, M. G. Denis, M. Campone, Combining two biomarkers, IDH1/2 mutations and 1p/19q codeletion, to stratify anaplastic oligodendroglioma in three groups: a single-center experience. Journal of Neuro-oncology. ,vol. 114, pp. 85- 91 ,(2013) , 10.1007/S11060-013-1152-0